Linked from

The 107 pages that link to Genetic testing, each with the reason it gives.

• Informed consentRelated: Consent may need to address incidental findings, privacy, and implications for relatives.

• DNARelated: DNA variants can inform diagnosis, risk assessment, and inherited-trait analysis.

• GeneRelated: Tests examine genes and other DNA regions for clinically relevant variants.

• MosaicismRelated: Test results depend on whether sampled tissue contains the altered cell lineage.

• Personalized medicineRelated: It reveals inherited or acquired variants relevant to diagnosis and treatment.

• BioethicsRelated: Testing raises questions about privacy, family disclosure, discrimination, and informed choice.

• Cat coat geneticsRelated: Tests can identify known coat-color variants and help distinguish carriers from affected cats.

• Familial hypercholesterolemiaRelated: A pathogenic variant can confirm the diagnosis and clarify which relatives may need testing.

• Sudden cardiac deathRelated: Testing can clarify inherited risk, but uncertain variants complicate decisions for families.

• AtaxiaRelated: It can establish a molecular diagnosis for inherited ataxia syndromes.

• Human genetic variationRelated: Testing makes variation actionable while raising questions about interpretation and consent.

• Duchenne muscular dystrophyRelated: Testing can confirm a DMD mutation and identify its specific type.

• Hypertrophic cardiomyopathyRelated: Testing can clarify familial risk and guide screening of relatives when a disease-causing variant is found.

• Androgen insensitivity syndromeRelated: Testing the androgen receptor gene can confirm many suspected cases.

• CardiomyopathyRelated: Testing can clarify inherited cardiomyopathy and guide evaluation of relatives.

• Genetic heterogeneityRelated: Testing can distinguish among different genetic causes of a shared clinical picture.

• Muscular dystrophyRelated: It can confirm a muscular dystrophy subtype and clarify inheritance within a family.

• Genetic disorderRelated: Testing can confirm a diagnosis, identify carriers, or clarify inherited risk.

• Dilated cardiomyopathyRelated: Testing can clarify inherited disease and inform screening of relatives.

• Medical geneticsRelated: It supplies evidence used to diagnose inherited conditions and guide care.

• Molecular geneticsRelated: Molecular findings can support diagnosis, risk assessment, and treatment choices.

• Fabry diseaseRelated: Testing the GLA gene confirms many diagnoses and identifies affected family members.

• LeukodystrophyRelated: Testing can confirm a suspected leukodystrophy and support family counseling.

• MicrocephalyRelated: It may establish a genetic cause, particularly when microcephaly occurs with other findings or in relatives.

• AchromatopsiaRelated: Testing can confirm a molecular cause and support family counseling.

• Cat breedingRelated: Testing can reveal variants that pedigree records alone cannot detect.

• Short statureRelated: Testing can clarify suspected inherited or chromosomal causes of short stature.

• Alport syndromeRelated: Testing COL4A3, COL4A4, and COL4A5 can confirm diagnosis and clarify inheritance.

• Gilbert syndromeRelated: Testing can identify UGT1A1 variants, though it is not usually needed for typical cases.

• MyopathyRelated: It can establish the cause of inherited myopathies and inform family counseling.

• PorphyriaRelated: After biochemical identification, it can confirm the inherited defect and support family testing.

• Bardet–Biedl syndromeRelated: Testing can confirm a suspected diagnosis and identify the BBS gene involved.

• ChoreaRelated: Testing can confirm inherited causes such as Huntington’s disease, but does not explain every chorea presentation.

• CiliopathyRelated: Testing can identify disease-causing variants and clarify which ciliopathy is present.

• CystinuriaRelated: Testing SLC3A1 and SLC7A9 can clarify the molecular cause and inheritance.

• Liddle syndromeRelated: Testing SCNN1B, SCNN1G, or SCNN1A can confirm an inherited channel disorder.

• Noonan syndromeRelated: Testing can confirm a suspected diagnosis and clarify inheritance and family recurrence risk.

• Primary immunodeficiencyRelated: A molecular diagnosis can clarify inheritance, prognosis, and family testing.

• Spinocerebellar ataxiaRelated: Testing can identify the causative subtype when clinical features alone cannot.

• Apert syndromeRelated: Testing FGFR2 can confirm the molecular diagnosis of Apert syndrome.

• Bartter syndromeRelated: Testing can confirm a molecular subtype and guide family counseling.

• Dubin–Johnson syndromeRelated: Testing ABCC2 can confirm the inherited cause when clinical findings are uncertain.

• Krabbe diseaseRelated: GALC variant analysis helps confirm diagnosis and clarify inheritance in a family.

• Metachromatic leukodystrophyRelated: Testing ARSA and PSAP can confirm the molecular cause and support family counseling.

• Waardenburg syndromeRelated: Testing can help identify a molecular cause and clarify the syndrome subtype.

• Xeroderma pigmentosumRelated: Testing can confirm XP and distinguish its molecular subtypes.

• Alexander diseaseRelated: Finding a pathogenic GFAP variant can confirm the diagnosis.

• Charcot–Marie–Tooth diseaseRelated: Testing can confirm a CMT subtype and clarify inheritance within a family.

• Cockayne syndromeRelated: Testing ERCC6 and ERCC8 can confirm many suspected cases and support family counseling.

• Congenital insensitivity to painRelated: Testing can distinguish causes such as NTRK1, SCN9A, PRDM12, and NGF variants.